期刊文献+

4种解释系统对HIV-1基因型耐药解释相关性评价

Evaluation of the Correlation of Four System for Testing HIV-1 Genotype Drug Resistance
下载PDF
导出
摘要 目的:比较HIVDB(7.0.1)、ANRS(25_09/2015)、REGA(9.1.0)和HIV GRADE(12/2015)4种解释系统对HIV-1基因型耐药结果解释的一致性。方法:选取我国3种主要HIV-1流行亚型和流行重组模式(B’、CRF01_AE和CRF07_BC),每种选取200条序列,共600条序列。分别用4种解释系统进行耐药结果分析,分为耐药(R)、中度耐药(I)和敏感(S)3个水平。对4种结果进行统计学分析。结果:4种系统基因型耐药解释结果比较相关性较高(r均>0.57,P均<0.01)。针对亚型来说,CRF07_BC的解释结果相关性最高,其次为B’亚型,CRF01_AE略低。结论:对于我国主要流行的HIV来说,4种解释系统对11种常用的抗病毒治疗药物耐药结果的解释具有较好的一致性。 Objective:To compare the correlation of four drug-resistance interpretation system including HIVDB, ANRS, REGA and HIV GRADE for testing HIV-1 genotype drug resistance. Methods:Trendy subtypes and restructuring model of HIV-1 including B’,CRF01AE and CRF07BC were selected,each genotype was 200 series,600 samples were analyzed by four drug-resistance interpretation system, the results were divided into three levels including resistance (R), possible drug-resistance (I) and susceptible (S). Results:Four drug-resistance interpretation system had a high correlation in genotypic drug-resistance consequence (rs〉0.57, P〈0.01), CRF07BC had the highest correlation, followed by subtype B, CRF01AE was slightly lower.Conclusion:Four drug-resistance interpretation system has a high correlation in analyzing antiviral drug resistance for major epidemic of HIV in China.
作者 赫天一 关琪
出处 《沈阳医学院学报》 2016年第4期237-241,共5页 Journal of Shenyang Medical College
基金 辽宁省自然科学基金项目(No2013020210) 沈阳市科技计划项目(F16-206-9-15) 沈阳医学院科技基金项目(No20142049 20123044)
关键词 HIV-1 基因型耐药解释系统 耐药突变 HIV-1 genotype resistant interpretation system drug-resistant mutation
  • 相关文献

参考文献19

  • 1Sterrantino G, Zaccarelli M, Di Biagio A, et al.Darunavirbased dual therapy of treatment-experienced HIV-infected patients:analysis from a national multicenter database[J]. Infection, 2015,43(3):339-343.
  • 2Frange P, Assoumou L, Descamps D, et al.HIV-1 subtype B-in-fected MSM may have driven the spread of transmitted resistant strains in France in 2007-12:impact on susceptibility to first-line strategies[J]. J Antimicrob Chemother, 2015, 70(7):2084-2089.
  • 3Houssaini A,Assoumou L,Miller V,et al.Scoring methods for building genotypic scores:an application to didanosine resistance in a large derivation set[J].PLoS One,2013,8(3):e59014.
  • 4Meixenberger K, Yousef KP, Somogyi S, et al.Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany[J].J Int AIDSSoc,2014,17(4 Suppl 3):19746.
  • 5Kim JY, Kim EJ, Choi JY, et al. Genetic variation of the HIV-1 integrase region in newly diagnosed anti-retroviral drugna?ve patients with HIV/AIDS in Korea[J]. Clin Microbiol Infect,2011,17(8):1155-1159.
  • 6Xing H, Wang X, Liao L, et al. Incidence and associated factors of HIV drug resistance in Chinese HIV-infected patients receiving antiretroviral treatment[J]. PLoS One, 2013, 8(4):e62408.
  • 7国务院防治艾滋病工作委员会办公室,联合国艾滋病专题工作组.中国艾滋病防治联合评估报告(2007)[R].北京,2007:8-9.
  • 8Gonzalez D, Digmann B, Barralon M, et al. Comparison of HIV-1 drug resistance profiles generated from novel software applications for routine patient care[J].J Int AIDS Soc,2014, 17(4 Suppl3):19751.
  • 9Snoeck J,Kantor R,Shafer RW,et al.Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent[J]. Antimicrob Agents Chemother, 2006,50(2):694-701.
  • 10李晶,蒋岩,吕超,汪静,姚均.三种HIV-1基因型耐药检测方法的一致性评价[J].中华预防医学杂志,2013,47(11):1050-1055. 被引量:5

二级参考文献36

  • 1Tian Xin CHU,Judith A LEVY.Injection drug use and HIV/AIDS transmission in China[J].Cell Research,2005,15(11):865-869. 被引量:17
  • 2[1]Deenan P,Stephen D R.Incidence and impact of resistance against approved antiretroviral drugs.Rev Med Virol,2000,10(4):231-253
  • 3[2]Hillard W,Richard R,Walid H,et al.Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type-1 seroconverters in the United States,1993-1998.J Infect Dis,2000,182(1):330-333
  • 4[3]Arnold F,Michele C,Brian L.Cellular factors for resistance against antiretroviral agents.Antivir Ther,2000,5:181-185
  • 5[4]William A,O'Brien.Resistance against reverse transcriptase inhibitors.Cli Infect Dis,2000,30(suppl2):185-192
  • 6[5]Hong-Qiang G,Paul L,Boyer,et al.The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.J Mol Biol,2000,300:403-418
  • 7[6]Omrani AS,Pillay D.Multi-drug resistant HIV-1.J Infection,2000,411(1):5-11
  • 8[7]Susan M.NNRTIs-a new class of drug for HIV.J Anti Chemo,2000,45(4):417-418
  • 9[8]Sergei G,John W E.HIV protease,enzyme function and drug resistance.Vitam Horm,2000,58:213-256
  • 10[9]Anne D S,Victor DeG,Monique,et al.Methods for investigation of the relationship between drug-susceptibility phenotype and human immunodeficiency virus type 1 genotype with applications to AIDS clinical trials group 333.J Infect Dis,2000,182(1):59-67

共引文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部